Stem Cells Spin S.A.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2011-02-09
Share capital
7,833,650.00 PLN
Registered address
Teofila Lenartowicza 6, 51-140 Wrocław, Poland
Electronic delivery address
AE:PL-44979-36099-SRVAV-27

Financials

Revenue history (in k)

From the notes

Current income tax (CIT due)$0

Filing timeliness

Financial statements were filed on time, on average 23 days early. All were audited by a statutory auditor.

  • 202501/07/2026
  • 202402/07/2025
  • 202304/07/2024
  • 202205/07/2023
  • 202112/07/2022
  • 202020/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Stock quotes

PLN 0.51
0.00 (0.00%)
0.480.500.520.540.5110:0012:0014:0016:00
Open
PLN 0.52
High
PLN 0.54
Low
PLN 0.47
Volume
2.79K
Avg. vol.
718.7
Market cap
PLN 21.08M
P/E ratio
–
EPS
-PLN 0.02
Shares outstanding
41.34M
52-week
PLN 0.44 – 0.54
Dividend yield
–
Dividend
–
Ex dividend date
–
Exchange
NewConnect

Quarterly results

PeriodRevenueEBITNet profit
Q2 2026USD 4.86kUSD -41.60kUSD -41.60k
Q1 2026USD 1.89kUSD -45.11kUSD -45.11k
Q4 2025USD 8.29kUSD -36.41kUSD -36.41k
Q3 2025USD 6.28kUSD -29.13kUSD -29.38k

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 68%
Sector · Manufacturing17,008 / 24,548
Top 69%
City · Wrocław6,171 / 13,650
Top 45%
Voivodeship · Dolnośląskie11,660 / 23,831
Top 49%
Country · Poland148,685 / 297,069
Top 50%

Results vs industry

Revenue
This companyUSD 287.71kMedianUSD 913.43kAverageUSD 25.82m
Net profit
This companyUSD -132.00kMedianUSD 14.22kAverageUSD 2.77m
Operating costs
This companyUSD 417.72kMedianUSD 846.99kAverageUSD 21.42m
Assets
This companyUSD 2.40mMedianUSD 897.46kAverageUSD 31.52m

Websites

  • stemcellsspin.com.plstemcellsspin.com.pl
    LiteSpeed
  • revitacell.plRevitacell – innowacyjne kosmetyki z komórek macierzystych | Skuteczne biodermokosmetyki
    WooCommerce 11.1WordPress 7.1Google Tag ManagerLiteSpeed
  • stemcellsspin.plStem Cells Spin - wynalazki, patenty, komórki macierzyste MIC-1
    LiteSpeed

Trademarks

The company holds 1 active trademark registered with the Polish Patent Office. 5 marks have expired or were not registered. The first mark was filed in 2010.

MarkNumberClassesStatusProtected until
revitacell (word)Z.3912583, 5, 29Protected Oct 7, 2031
revitacell Z.3990873, 5, 29Expired –
Stem Cells Spin Z.3913811, 3, 5, 39, 42, 44Expired –
Velvetyna Z.3912603, 5, 29Expired –
biocervin Z.3912613, 5Expired –
MarkProtected until
revitacell (word)Oct 7, 2031
revitacell –
Stem Cells Spin –
Velvetyna –
biocervin –

Authorized Representatives

Adam Symber age 46 – Vice President of the Management Board
Magdalena Cegielska age 45 – President of the Management Board
Wojciech Grzegorczyk age 46 – Attorney-in-fact (joint)

Manner of representation

One member of the management board is authorized to submit declarations of will on behalf of the company and to represent it in the case of a one-person management board, or two members of the management board jointly or a member of the management board jointly with a commercial proxy in the case of a multi-member management board.

Supervisory board

Marek Andrzej Cegielski age 74 – Supervisory Board Member
Andrzej Trznadel age 64 – Supervisory Board Member
Tomasz Gębarowski age 50 – Supervisory Board Member
Joanna Holanowska age 44 – Supervisory Board Member
Piotr Okoniewski age 60 – Supervisory Board Member

Beneficial owners

Stem Cells Spin is a public company listed on NewConnect, so it does not report beneficial owners to the CRBR (Art. 58 of the Polish AML Act). Its shareholders are disclosed in stock-exchange reports.

Bank accounts

Registered as a VAT taxpayer on 2009-04-08.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Buildings and premises
PLN 2,422

Public aid

10 public aid cases recorded, with a total value of $556,898.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
–
De minimis aid (in accordance with Commission Regulation 2023/2831)
–
De minimis aid (in accordance with Commission Regulation 2023/2831)
–

European Funds

ProjectEU co-financing
Development of a hydrogel containing homogenate of hair-inducing stem cells with a neuroprotective effect on spinal cord tissue
$510.8K

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Labor Przedsiębiorstwo Farmaceutyczno - Chemiczne sp. z o.o.
Biomar sp. z o.o.
Przedsiębiorstwo Farmaceutyczne Leki Natury Tadeusz Polański sp. z o.o.
Human Biome S.A.
Zeptor Polska sp. z o.o.
F1 Pharma S.A.
Ti-Com sp. z o.o.
Lideo S.A.
Munar Pharma S.A.
Amplicon sp. z o.o.

Change history

DateEvent
2026-09-17Share capital increase
2018-07-23Share capital increase
2015-04-23PKD change
2015-03-10PKD change
2014-01-13Share capital increase

FAQ

Last updated: 2026-09-17